BB vs JAZZ · P/E 117, rev $549.1M vs P/E 1988, rev $4.07B
BlackBerry Ltd (BB) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
BB currently screens at market cap $6.14B and trailing P/E 116.5. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the BB and JAZZ stock pages for the full models.
Not investment advice.